Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Merck
Mallinckrodt
AstraZeneca
McKinsey
Farmers Insurance
Boehringer Ingelheim
Dow
Moodys
Novartis

Generated: October 19, 2017

DrugPatentWatch Database Preview

CEFPROZIL Drug Profile

« Back to Dashboard

What is the patent landscape for Cefprozil, and when can generic versions of Cefprozil launch?

Cefprozil is a drug marketed by Ranbaxy Labs Ltd, Teva, Apotex Inc, Wockhardt, Sandoz, Teva Pharms, Aurobindo Pharma Ltd, Lupin, Orchid Hlthcare, and Aurobindo Pharma. and is included in fifteen NDAs.

The generic ingredient in CEFPROZIL is cefprozil. There are thirteen drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the cefprozil profile page.

Summary for Tradename: CEFPROZIL

US Patents:0
Applicants:10
NDAs:15
Suppliers / Packagers: see list20
Bulk Api Vendors: see list42
Clinical Trials: see list13
Patent Applications: see list3,607
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CEFPROZIL at DailyMed

Pharmacology for Tradename: CEFPROZIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Orchid Hlthcare
CEFPROZIL
cefprozil
FOR SUSPENSION;ORAL065284-001Dec 30, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
Ranbaxy Labs Ltd
CEFPROZIL
cefprozil
TABLET;ORAL065198-001Dec 13, 2006DISCNNoNo► Subscribe► Subscribe► Subscribe
Ranbaxy Labs Ltd
CEFPROZIL
cefprozil
FOR SUSPENSION;ORAL065202-001Jun 30, 2006DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz
CEFPROZIL
cefprozil
FOR SUSPENSION;ORAL065257-002Dec 8, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
Lupin
CEFPROZIL
cefprozil
TABLET;ORAL065276-002Dec 8, 2005ABRXNoYes► Subscribe► Subscribe► Subscribe
Wockhardt
CEFPROZIL
cefprozil
TABLET;ORAL065428-001Jun 14, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva
CEFPROZIL
cefprozil
TABLET;ORAL065208-002Dec 6, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms
CEFPROZIL
cefprozil
FOR SUSPENSION;ORAL065236-002Dec 8, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
Lupin
CEFPROZIL
cefprozil
FOR SUSPENSION;ORAL065261-002Dec 19, 2005ABRXNoYes► Subscribe► Subscribe► Subscribe
Wockhardt
CEFPROZIL
cefprozil
TABLET;ORAL065428-002Jun 14, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Farmers Insurance
Express Scripts
Johnson and Johnson
Argus Health
Teva
Cantor Fitzgerald
McKinsey
Fuji
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot